Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT07255066

Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial

Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial — Recruiting • Non-phase study • Oncology • NCT07255066.

📅 22 Sep 2026 ⏱ 3 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07255066
Sponsor
University of Edinburgh
Start
2026-04-01
ClinicaliQ Trial Snapshot
  • Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial — Recruiting • Non-phase study • Oncology • NCT07255066.
  • Intervention tested: An EPA-enriched (eicosapentaenoic acid) nutritional intervention is being evaluated in a randomised controlled trial to address malnutrition in cancer patients, with the aim of improving weight maintenance, muscle strength, and overall nutritional status.
  • Patient eligibility overview: The trial targets cancer patients experiencing malnutrition-related complications including weight loss and muscle weakness, who are at risk of treatment delays or reduced treatment efficacy due to poor nutritional status.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Malnutrition is a common and serious issue for people living with cancer. Many cancer patients experience weight loss, muscle weakness, and poor quality of life due to malnutrition. This can also reduce the success of cancer treatments, increase hospital visits, and add emotional distress for both patients and their loved ones. Treating malnutrition through good nutritional care is increasingly recognised as an important part of cancer treatment. Leading experts recommend that all cancer patients be checked for signs of malnutrition and given personalised nutrition plans when necessary. While dietary counselling…

Eligibility Snapshot
  • : * Participants with stage III-IV lung and/or colorectal cancer undergoing systemic anti-cancer treatment (SACT) or starting SACT within the next 4 weeks *with non-curative intent * Participants aged 18 or older * Participants at nutritional risk defined as a BMI 10 mg/dL) * Participants with an ECOG-PS*** score of 0, 1 or 2 * Participants willing and able to give written informed consent

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
‘My cancer spread while I waited months for surgery’: The cost of England’s cancer wait times
Oncology · BBC Health · 10 Sep 2026
England's cancer surgery waiting times have deteriorated despite government initiatives aimed at improving them, with patients experiencing significant delays that may allow…
View brief →
Clinical Brief
Wellbeing support demand for cancer patients grows
Oncology · BBC Health · 25 Oct 2026
Key Takeaways for Clinical Practice Cancer patients are reporting increased demand for wellbeing support services, suggesting current provision may not meet patient…
View brief →
Clinical Brief
The Irish international rugby ‘trailblazer’ and her legacy of cancer awareness
Oncology · BBC Health · 30 Sep 2026
A prominent Irish rugby player's death from breast cancer highlights the importance of raising awareness about symptoms among younger women, even in…
View brief →
Clinical Brief
Expert team to drive improvements in cancer care
Oncology · NHS England · 20 Sep 2026
Government establishes National Cancer Board to coordinate and drive improvements across cancer care services in the UK Board's inaugural meeting today (21…
View brief →
Clinical Brief
‘Quick skin cancer pathway the best birthday gift’
Oncology · BBC Health · 09 Sep 2026
Key Takeaways for Clinical Practice Early referral through skin cancer fast-track pathways enables rapid diagnosis and treatment, improving outcomes for melanoma patients
View brief →
Guideline
Durvalumab with platinum-based chemotherapy, then with or without olaparib, for untreated advanced or recurrent endometrial cancer
Oncology · 09 Sep 2026
Durvalumab combined with platinum-based chemotherapy is the recommended first-line treatment for untreated advanced or recurrent endometrial cancer, with olaparib addition considered based…
View guideline →